IL-13Rα2-positive cancers showed 36% (56/156) invasion of peripancreatic neuroplexus (PL), while IL-13Rα2-negative cancer showed only 16% (13/80) in the combined data from both hospitals (Table 3). Here, IL13RA2 is linked to cancer.